Mirati Therapeutics Inc. (MRTX)
NASDAQ: MRTX
· Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM
Mirati Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -725.88M | -737.53M | -737.07M | -740.87M | -738.01M | -644.5M | -634.49M | -581.78M | -483.25M | -490.53M | -406.96M |
Depreciation & Amortization | 4.19M | 3.79M | 3.38M | 2.93M | 2.6M | 2.4M | 2.12M | 1.78M | 1.43M | 1.09M | 809K |
Stock-Based Compensation | 192.52M | 190.96M | 190.24M | 186.19M | 158.46M | 142.4M | 131.69M | 113.5M | 101.37M | 96.18M | 89M |
Other Working Capital | 80.43M | 87.39M | 66.65M | 25.94M | 2.34M | 2.34M | 2.34M | -7.04M | -25.58M | -25.52M | -22.58M |
Other Non-Cash Items | 244.1M | 116.41M | -19.83M | -8.72M | 1.23M | 10.54M | 13.22M | 12.11M | 3.85M | -6.53M | -10.83M |
Deferred Income Tax | -266.38M | -144.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -42.64M | -17.66M | -37M | -10.1M | -4.03M | 188K | 48.62M | 65.59M | 49.37M | 42.82M | 5.04M |
Operating Cash Flow | -594.1M | -588.19M | -600.28M | -570.57M | -579.75M | -488.98M | -438.85M | -388.8M | -327.24M | -356.97M | -322.94M |
Capital Expenditures | -1.84M | -3.04M | -3.98M | -4.85M | -6.69M | -7.46M | -9.83M | -9.79M | -8.65M | -8.08M | -5.25M |
Cash Acquisitions | -209.62M | -286.97M | -270.71M | -75.29M | -15.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -942.75M | -978.99M | -870.87M | -956.7M | -1.08B | -998.31M | -1.01B | -1.42B | -1.27B | -1.04B | -1.05B |
Sales Maturities Of Investments | 1.15B | 1.27B | 1.25B | 1.19B | 1.09B | 988.2M | 939.62M | 843.62M | 796.61M | 638.71M | 586.19M |
Other Investing Acitivies | 209.62M | 286.97M | 375.38M | 230.65M | 2.36M | -10.11M | -73.99M | -579.11M | -468.75M | -405.87M | -467.91M |
Investing Cash Flow | 207.79M | 283.93M | 371.4M | 225.8M | -4.33M | -17.57M | -83.82M | -588.9M | -477.4M | -413.95M | -473.16M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 346.19M | 168.59M | 166.14M | 166.94M | 640.31M | 491.43M | 497.86M | 505.22M | 915.83M | 919.95M | 921.4M |
Financial Cash Flow | 346.19M | 168.59M | 166.14M | 166.94M | 640.31M | 491.43M | 497.86M | 505.22M | 915.83M | 919.95M | 921.4M |
Net Cash Flow | -40.13M | -135.74M | -62.77M | -177.82M | 56.22M | -15.12M | -24.81M | -472.48M | 111.19M | 149.03M | 125.3M |
Free Cash Flow | -595.93M | -591.23M | -604.26M | -575.42M | -586.45M | -496.44M | -448.68M | -398.6M | -335.89M | -365.05M | -328.19M |